Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2014 08:25 ET | Source: Intersect ENT

Photo Release -- Intersect ENT Announces Positive Data From Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis

MENLO PARK, Calif. and Orlando, Fla., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat...
September 17, 2014 17:58 ET | Source: Intersect ENT

Intersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population

MENLO PARK, Calif., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
September 03, 2014 16:01 ET | Source: Intersect ENT

Intersect ENT Reports Second Quarter 2014 Results

MENLO PARK, Calif., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
August 22, 2014 08:05 ET | Source: Intersect ENT

Intersect ENT to Announce Second Quarter Financial Results

MENLO PARK, Calif., Aug. 22, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today...
August 11, 2014 08:05 ET | Source: Intersect ENT

Study Indicates Cost Effectiveness of Intersect ENT's PROPEL Implant for Chronic Sinusitis

MENLO PARK, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today...
July 29, 2014 16:05 ET | Source: Intersect ENT

Intersect ENT Announces Closing of its Initial Public Offering

MENLO PARK, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a commercial drug-device company committed to improving the quality of life for patients with ear, nose and...
July 24, 2014 08:05 ET | Source: Intersect ENT

Intersect ENT Announces Pricing of Its Initial Public Offering

MENLO PARK, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life for patients with ear, nose and throat...